J Biol Chem, Vol. 274, Issue 37, 26454-26460, September 10, 1999
Nucleotide-regulated Calcium Signaling in Lung Fibroblasts and
Epithelial Cells from Normal and P2Y2 Receptor (
/
)
Mice*
László
Homolya
§,
William C.
Watt
,
Eduardo R.
Lazarowski
,
Beverly H.
Koller
, and
Richard C.
Boucher
¶
From the
Cystic Fibrosis/Pulmonary Research and
Treatment Center, University of North Carolina, Chapel Hill, North
Carolina 27599 and the § Membrane Research Group of
Hungarian Academy of Sciences in the National Institute of Haematology
and Immunology, Budapest, H-1113, Hungary
 |
ABSTRACT |
To test for the role of the
P2Y2 receptor (P2Y2-R) in the regulation
of nucleotide-promoted Ca2+ signaling in the lung, we
generated P2Y2-R-deficient (P2Y2-R(
/
)) mice
and measured intracellular Ca2+i responses
(
Ca2+i) to nucleotides in cultured lung
fibroblasts and nasal and tracheal epithelial cells from wild type and
P2Y2-R(
/
) mice. In the wild type fibroblasts, the rank
order of potencies for nucleotide-induced
Ca2+i
was as follows: UTP
ATP
ADP > UDP. The responses induced by these agonists were completely absent in the
P2Y2-R(
/
) fibroblasts. Inositol phosphate responses
paralleled those of
Ca2+i in both groups. ATP
and UTP also induced Ca2+i responses in wild type
airway epithelial cells. In the P2Y2-R(
/
) airway
epithelial cells, UTP was ineffective. A small fraction (25%) of the
ATP response persisted. Adenosine and
,
-methylene ATP were
ineffective, and ATP responses were not affected by adenosine deaminase
or by removal of extracellular Ca2+, indicating that
neither P1 nor P2X receptors mediated this residual ATP response. In
contrast, 2-methylthio-ADP promoted a substantial Ca2+i response in P2Y2-R(
/
) cells,
which was inhibited by the P2Y1 receptor antagonist
adenosine 3'-5'-diphosphate. These studies demonstrate that
P2Y2-R is the dominant purinoceptor in airway epithelial
cells, which also express a P2Y1 receptor, and that the
P2Y2-R is the sole purinergic receptor subtype mediating nucleotide-induced inositol lipid hydrolysis and Ca2+
mobilization in mouse lung fibroblasts.
 |
INTRODUCTION |
Extracellular ATP induces a wide variety of responses in many cell
types, including muscle contraction and relaxation, vasodilation, neurotransmission, platelet aggregation, ion transport regulation, and
cell growth (1-3). The cell surface receptors mediating these diverse
effects of ATP were originally termed P2 purinoceptors to distinguish
them from the adenosine-activated P1 purinoceptors (4). Subsequently,
pyrimidine nucleotides were also shown to regulate a broad range of
cell functions, leading to speculation about the existence of separate
pyrimidoceptors (5, 6). It is likely, however, that a common receptor
for uridine and adenine nucleotides is present in many cell types,
including neutrophils, pituitary cells, skin fibroblasts, smooth muscle
cells, and specific endothelial and epithelial cell types (2). This
receptor was originally named the P2U purinoceptor but has been
subsequently reclassified as the P2Y2 receptor
(P2Y2-R).1 The
cloning of the murine P2Y2-R gene (7) and its
human counterpart (8) made possible the definitive identification of
this signaling protein as a G-protein and phospholipase C-coupled
receptor that is equipotently activated by ATP and UTP but not by
diphosphate nucleotides (9-11).
The lack of specific agonists or antagonists for the growing number of
nucleotide receptor subtypes (e.g. seven P2X and five P2Y
receptors have been identified to date (12, 13)) constitutes a major
obstacle in identifying the specific nucleotide receptor mediating a
given cellular function. One example of the difficulty in assigning
receptor subtypes to cellular responses is illustrated in studies of
fibroblasts. Following original studies by Okada et al.
(14), who observed that ATP induced change in the membrane potential of
mouse L cells and human fibroblasts, a variety of adenosine- and
ATP-induced responses in fibroblasts were reported. These actions of
adenosine and ATP, which include regulation of cell growth,
cytoskeletal contraction, Ca2+ efflux, and LDH and
nucleotide release (15-19), were proposed to be mediated by
A1, A2, P2X, P2Z (in current terminology
P2X7), and P2Y1 receptors (15-23). In one
study with human skin fibroblasts, actions of ATP on Ca2+
mobilization and phospholipase C activity were mimicked by UTP (24),
although no further characterization of the receptor(s) mediating UTP
responses in fibroblasts was provided.
The effects of extracellular nucleotides have also been extensively
studied on airway epithelia, and attempts have been made to link the
cellular responses to specific nucleotide receptors. Both ATP and UTP
equipotently regulate epithelial electrolyte and water transport (3,
25), trigger mucin secretion (26, 27), and increase ciliary beat
frequency (28-30). ATP and UTP equipotently stimulate inositol
phosphate formation (29) and Ca2+i mobilization and
exhibit cross-desensitization (3). These data suggest that a common
receptor for ATP and UTP is expressed on the airway epithelia, which
pharmacologically is most likely to be the P2Y2-R. However,
receptors that are activated by UDP (31) and adenosine (32) may also be
expressed on these cells and thus complicate this analysis.
In this study, we generated a mouse line carrying a mutant
P2Y2 allele. We used these mice to examine the
relative role of P2Y2-R in the nucleotide-promoted
Ca2+ signaling in mouse lung fibroblasts and airway
epithelial cells. The role of P2Y2-R was tested by
comparison of nucleotide-stimulated Ca2+i responses
in cells from P2Y2-R (
/
) mice with those from wild type
animals. In the accompanying paper (33), the role of P2Y2-R
in mediating Cl
secretory responses in freshly excised
tracheal, gallbladder, and jejunal tissues is described.
 |
MATERIALS AND METHODS |
Generation of P2Y2-R-deficient Mice--
A targeting
vector was designed such that DNA corresponding to base pairs 552-1149
of the published P2Y2-R cDNA was replaced with the
neomycin gene upon integration of the targeting plasmid into the genome
by homologous recombination. The targeting plasmid contains two regions
of DNA with homology to the endogenous locus. The targeting vector was
constructed by cloning two genomic DNA fragments into the JNS2 vector:
a 2500-base pair fragment extending from an XhoI site in the
5' region of the gene to a SmaI site located at base pair
552 of the published cDNA and a fragment extending 6500 bases 3'
from the EagI site at base pair 1149 of the coding sequence.
The targeting vector was electroporated into E142aTG cells, and
resulting neomycin- and gancyclovir-resistant colonies were isolated.
DNA from surviving colonies was isolated, digested with
BamHI, and analyzed by Southern blot analysis using a probe
located immediately upstream of the
P2Y2-R genomic fragments not included
in the targeting vector. Chimeric mice were generated with
P2Y2-R-targeted E142aTG cell lines and were bred to B6D2 mice. Offspring were identified by Southern blot analysis of tail DNA,
using probes described above.
Total cellular RNA was isolated from kidneys of P2Y2-R(+/+)
and P2Y2-R(
/
) mice with RNAzol B
(TelTest, Inc., Friendswood, TX), as per the manufacturer's
instructions. Twenty µg of RNA were electrophoresed in a 1.2%
agarose formaldehyde gel, blotted to an Immobilon-NC transfer membrane
(Millipore Corp., Bedford, MA), and UV-cross-linked. The membranes were
hybridized with a 32P-labeled P2Y2-R cDNA
for 1 h at 68 °C using Quikhyb reagent (Stratagene, La Jolla,
CA), and blots were washed twice with 2× SSC, 0.1% SDS and once with
0.2× SSC, 0.1%SDS at 42 °C for 15 min each. The P2Y2-R
cDNA corresponds to base pairs 267-1097.
For histological analysis, all animals were exsanguinated by severing
the aorta after receiving an intraperitoneal injection of a lethal dose
of chloral hydrate (1 ml of a 20 mg/ml solution). Organs were immersed
in 10% phosphate-buffered neutral formalin (pH 7.0) for at least
24 h. The organs then were embedded in paraffin, dehydrated, and
sectioned for histological analysis with hematoxylin and eosin.
Adult mice (wild type and P2Y2(
/
)) of both sexes were
used in this investigation. All animals were bred and raised at the University of North Carolina at Chapel Hill. All mice were allowed food
and water ad libitum until euthanized.
Cell Culture--
Wild type and P2Y2-R(
/
) mice
were euthanized with 100% CO2. Lung fibroblasts were
isolated by mincing freshly excised lung parenchyma into
~1-mm3 pieces and establishing explant cultures on
plastic tissue culture plates in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum. Outgrowth fibroblasts were
harvested with 0.1% trypsin plus 1 mM EDTA in
phosphate-buffered saline 1-3 weeks after initial plating. The cells
were seeded on glass coverslips coated with 0.3 mg/ml Vitrogen
(Collagen Biomaterials, CA) and cultured for 36-48 h. Nearly confluent
cultures were used for study.
To isolate epithelial cells, the trachea and nasal turbinates were
removed from the animals and dissected free of blood vessels and
connective tissues. The airway epithelial cells were disaggregated from
the tissues by a 4-h treatment with 0.1% protease XIV (Sigma), epithelial cells isolated by centrifugation, and cells were seeded at a
5 × 105 cells/cm2 density on
Vitrogen-coated glass coverslips. The cells were allowed to attach for
24 h in Ham's F-12-based medium containing 10 µg/ml insulin, 5 µg/ml transferrin, 1 µM hydrocortisone, 30 nM triiodothyronine, 25 ng/ml epidermal growth factor, 3.75 µg/ml endothelial cell growth substance, 0.8 mM
Ca2+ (total), and an equal amount of 3T3
fibroblast-conditioned Dulbecco's modified Eagle medium containing 2%
fetal bovine serum, following which the cultures were gently washed and
maintained for an additional 24-36 h before study. Only well attached
cell clusters containing equal numbers of ciliated and nonciliated
cells were used for Ca2+i studies.
Ca2+i Measurements--
The cell cultures
were washed with hormone-free Ham's F-12 medium and incubated with 3 µM Fura-2/AM for 30 min at 37 °C. After the loading
period, the cells were washed twice with Ringer solution (130 mM Na+, 128 mM Cl
, 5 mM K+, 1.3 mM Ca2+, 1.3 mM Mg2+, 5 mM glucose, and 10 mM Hepes, pH 7.4) and mounted in a microscope chamber. The
fluorescence (>450 nm) of 30-50 cells was alternately acquired at
340- and 380-nm excitation by a RatioMaster RM-D microscope fluorimetry
system (Photon Technology Inc., Monmouth Junction, NJ) at room
temperature. A Zeiss Axiovert 35 microscope and a Nikon UV-F × 100 (1.3) glycerol immersion objective were used. After each
experiment, the cells were lysed with 40 µM digitonin, and the background fluorescence was determined by quenching technique using 4 mM MnCl2.
Inositol Phosphate Studies--
Inositol phosphate measurements
were performed as described previously (34). In brief, cells grown on
Vitrogen-coated glass coverslips were labeled overnight with 5 µCi/ml
myo-[3H]inositol in inositol-free Dulbecco's
modified Eagle's medium containing 4.5 g/liter glucose. The cells were
then preincubated with 10 mM LiCl for 15 min and challenged
with agonist for an additional 15 min. The incubations were terminated
by the addition of 5% ice-cold trichloroacetic acid. The accumulated
[3H]inositol phosphates were separated on Dowex AG1-X8
anion exchange columns and quantified in a scintillation counter
(31).
Reagents--
Hormones for cell culture were purchased from
Collaborative Research, Inc. (Bedford, MA) with the exception of
triiodothyronine, which was from Sigma; other cell culture materials
were purchased from Life Technologies, Inc. Molecular biology grade ATP
and UTP were purchased from Amersham Pharmacia Biotech (Uppsala,
Sweden). Hexokinase, UDP, ADP, and adenosine were from Roche Molecular Biochemicals. 2-methylthio-ATP (2-MeSATP), 2-methylthio-ADP (2-MeSADP),
,
-methylene ATP (
,
-meATP), and digitonin were obtained from RBI (Natick, MA). Fura-2/AM, Fura-2 pentapotassium salt, and
Ca2+ calibration buffers were purchased from Molecular
Probes, Inc. (Eugene, OR). myo-[3H]inositol
(20 Ci/mmol) was from ARC (St. Louis, MO). All other chemicals were
purchased from Sigma. To remove triphosphate contamination from
diphosphate nucleotides, 1 mM stock solutions of UDP, ADP, and 2-MeSADP were pretreated with 10 units/ml hexokinase for 30 min at
37 °C in the presence of 5 mM glucose (10).
Data Analysis--
For Ca2+i measurements,
the background corrected ratio values (340/380) were calibrated by
using the formula originally proposed by Grynkiewicz et al.
(35). The optical parameters of the system,
Rmax, Rmin, and
Kd values were determined by using 1 µM Fura-2 free acid and a series of Ca2+
buffers. Differences between the peak and basal
Ca2+i concentration were plotted. The data are
presented as mean ± S.E. For comparisons, the mean values were
analyzed by unpaired t tests. The significant differences
(p < 0.05) are indicated by asterisks.
 |
RESULTS |
Generation of P2Y2-R-deficient Mice--
Mice
deficient in P2Y2-R were generated by targeted mutagenesis
of the P2Y2-R gene in mouse embryonic
stem cells (Fig. 1A). RNA
isolated from kidneys of a P2Y2-R(+/+) and
P2Y2-R(
/
) mouse confirmed the complete loss
of P2Y2-R in the P2Y2 (
/
) mouse (Fig. 1B). Mice homozygous for the mutant
P2Y2-R allele were obtained at the expected
frequency, were fertile, and could not be distinguished from wild type
littermates. No differences were seen on histological analysis of all
organs analyzed, including the kidney, heart, testes, pancreas, liver,
trachea, lungs, salivary glands, and gastrointestinal tract.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
Targeted disruption of the
P2Y2-R gene.
A, construction of the P2Y2-R targeting vector.
B, confirmation of targeting by Northern blot analysis. RNA
was generated from kidneys of a P2Y2-R(+/+) and a
P2Y2-R( / ) mouse. P2Y2-R is present in the
kidneys of the wild type mouse but is absent in the kidneys of the
P2Y2-R( / ) mouse. B, BamH1; E,
EcoRI; S, SmaI; X, XbaI; N,
NotI.
|
|
Effects of Nucleotides on Inositol Phosphate Accumulation and
Intracellular Ca2+ Levels in Murine Lung
Fibroblasts--
The effects of nucleotides were studied in cultured
lung fibroblasts isolated from wild type and P2Y2-R(
/
)
mice. Changes in the intracellular Ca2+ concentration
([Ca2+]i) were monitored by using Fura-2
fluorescent indicator, and nucleotide-induced
[3H]inositol phosphate formation was measured in
myo-[3H]inositol-labeled cells (Fig.
2). In wild type fibroblasts, UTP and ATP
promoted dose-dependent Ca2+i (Fig.
2A) and inositol phosphate responses (Fig. 2B). ADP induced only a small Ca2+i response at high
concentrations. UDP had no substantial effect.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Concentration-effect curves for
nucleotide-stimulated Ca2+ responses
( Ca2+i) and
[3H]inositol phosphate formation in mouse lung
fibroblasts. Cells isolated from wild type (A, B) and
P2Y2-R( / ) mice (C, D) were exposed to the
indicated concentration of ATP ( ), UTP ( ), ADP ( ), or UDP
( ). Changes in Ca2+i were measured immediately
after the addition of agonist to Fura-2-loaded cells (top panels). Values are mean ± S.E. of changes from basal
to peak concentration (n = 3-12/concentration).
myo-[3H]Inositol-labeled cells were
preincubated with LiCl and subsequently challenged with the
indicated nucleotide for 15 min (B, D). Counts from
accumulated [3H]inositol phosphates over the background
were plotted. Each data point represents the mean ± S.E. of three
independent experiments performed in triplicate.
|
|
Both Ca2+i and inositol phosphate responses to
nucleotides were abolished in P2Y2-R(
/
) fibroblasts
(Fig. 2, C and D). Similarly, ADP and UDP did not
induce responses over background in these cells. These data indicate
that the P2Y2 receptor is the only nucleotide receptor
functionally expressed in murine lung fibroblasts.
Characterization of Nucleotide-induced Responses in Wild Type
Airway Epithelial Cells--
Primary murine airway epithelial cells
have a limited growth capacity. Therefore, in experiments with airway
epithelia, we focused only on Ca2+i measurements
and confined our pharmacologic characterizations to two concentrations
of nucleotide agonists. The two concentrations (1 and 100 µM) of nucleotides studied were selected on the basis of
previous studies of human nasal cells, where 100 µM ATP
and UTP induced a maximal effect, and their EC50 values
were in the low micromolar concentration range (3).
ATP and UTP promoted substantial Ca2+i responses at
both 1 and 100 µM concentrations in tracheal cells from
wild type mice (Fig. 3A). ADP,
2-MeSATP, and 2-MeSADP were effective only at the 100 µM
concentration, while UDP had no measurable effect. A similar pattern
was found in nasal cells (Fig. 3B), with the exception that,
in the latter, the maximal responses to 100 µM agonist
concentrations were generally smaller, whereas the 2-MeSATP and
2-MeSADP responses were relatively larger at the 1 µM
concentration.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide-induced Ca2+ responses
( Ca2+i) in wild-type
murine tracheal (A) and nasal (B)
epithelial cells. Changes in [Ca2+]i in
response to 1 and 100 µM concentrations of the indicated
nucleotide were measured in Fura-2-loaded airway epithelial cells
isolated from wild type mice. Maximal changes in
[Ca2+]i (from basal to peak) in response to the
agonists were plotted (n = 3-14).
|
|
To investigate possible cross-desensitization between agonists in
nucleotide-promoted Ca2+i responses, isolated
tracheal and nasal cells were exposed first to successive additions of
a 100 µM concentration of a given agonist until no
further change in Ca2+i signal was observed.
Subsequently, the cells were exposed to 100 µM of a
second agonist in the continued presence of the first one.
The results obtained from wild type tracheal cells are shown in Fig.
4. UTP pretreatment markedly, but not
completely, reduced the Ca2+i response to ATP (Fig.
4A), whereas ATP pretreatment completely abolished the
UTP-induced Ca2+i response (Fig. 4B).
Pretreatment with ADP, and 2-MeSATP had no significant effect on ATP or
UTP-induced Ca2+i responses (Fig. 4, A
and B). The Ca2+i signal elicited by
2-MeSATP was entirely abolished by ATP pretreatment (Fig.
4C). UTP or 2-MeSADP pretreatment also reduced, although
only partially, the 2-MeSATP-induced responses. These findings suggest
the functional expression of both a common receptor for ATP and UTP and
an additional adenine nucleotide receptor(s).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Desensitization of nucleotide-stimulated
Ca2+ responses in wild type tracheal and nasal epithelial
cells. A, B, and C, tracheal
Ca2+ responses induced by 100 µM ATP, UTP, or
2-MeSATP were measured following no preaddition (None) or
preaddition of a 100 µM concentration of the nucleotides
indicated at the bottom of each column.
Responsiveness of the cells was tested by adding 200 µM
carbachol after each individual experiment. The values are mean ± S.E. (n = 3-7). D, E, and
F, desensitization studies with wild type nasal epithelial
cells were performed with the same protocol detailed above. The
values are mean ± S.E. (n = 3-6). The
asterisks indicate significant differences between responses
with or without pretreatment (p < 0.05).
n.d., not determined)
|
|
Fig. 4 also summarizes the desensitization experiments performed with
wild type nasal epithelial cells. A partial cross-desensitization between ATP and UTP was observed in this cell type (Fig. 4,
D and E). Pretreatment with ADP did not
significantly alter the response induced by ATP or UTP, whereas
2-MeSATP pretreatment significantly attenuated both ATP- and
UTP-stimulated signals. The Ca2+i response to
2-MeSATP was eliminated by ATP or 2-MeSADP pretreatment (Fig.
4F). Taken together, these results are also consistent with
the expression of a common receptor for ATP and UTP and, possibly, an
additional ADP receptor.
Nucleotide-induced Ca2+ Responses in Airway Epithelial
Cells from P2Y2-R(
/
) Mice--
A potential candidate
for the common ATP/UTP receptor in airway epithelial cells is the
P2Y2 receptor. To test the involvement of P2Y2
receptor in the murine airway epithelium, Ca2+i
studies were performed on tracheal and nasal cells isolated from
P2Y2-R(
/
) mice. The UTP-induced
Ca2+i responses were abolished in both tracheal
(Fig. 5A) and nasal cells
(Fig. 5B). The magnitude of ATP-stimulated
Ca2+i responses was substantially reduced in
P2Y2-R(
/
) tracheal and nasal epithelial cells, but
residual Ca2+i responses were measurable. The
reductions in the responses to 100 µM ATP in wild type
and P2Y2-R(
/
) tracheal and nasal cells (Figs. 3 and 5,
respectively) were 74.5 and 44.0% (p < 0.02), respectively.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of nucleotides on tracheal
(A) and nasal (B) epithelial cells
isolated from P2Y2-R( / ) mice. For details, see the
legend of Fig. 2.
|
|
ADP, 2-MeSATP, and 2-MeSADP elicited Ca2+i
responses in both tracheal and nasal cells from
P2Y2-R(
/
) mice, whereas UDP had no substantial effect
in either. A slight reduction in responses induced by 100 µM ADP and 2-MeSATP was observed in the P2Y2-R(
/
) tracheal cells, but Ca2+i
responses induced by 100 µM 2-MeSADP in both
P2Y2-R(
/
) tracheal and nasal cells were not
significantly different from that found in wild type cells.
These results clearly demonstrate that the P2Y2 receptor is
the major but not the unique nucleotide receptor functionally expressed
in murine tracheal and nasal epithelial cells.
Identification of the Residual Nucleotide Receptor in
P2Y2-R(
/
) Airway Epithelial Cells--
Next, we
initiated a series of experiments to identify the nucleotide receptor
type(s) that accounted for the residual Ca2+i
responses induced by adenine nucleotides. To test for the involvement
of adenosine receptors in ATP-promoted responses, P2Y2-R(
/
) cells were exposed to 100 µM
ATP in the presence or absence of 1 unit/ml adenosine deaminase. In
tracheal cells, ATP stimulated a 65.4 ± 17 nM
(n = 3) change in Ca2+i in the
presence of enzyme, which was not significantly different from the
values obtained in its absence, 92.4 ± 40 nM (n = 10). In nasal cells, the ATP-induced
Ca2+ responses were 103.8 ± 65 (n = 4) and 108.9 ± 29 nM (n = 11) in the
presence and absence of adenosine deaminase, respectively. In addition,
no Ca2+i response was elicited by 100 µM adenosine in either tracheal or nasal epithelial cells
(1.5 ± 1.0 and 4.2 ± 0.2 nM, respectively
(n = 3)).
Next, we tested for the possible involvement of P2X receptors (36). To
investigate this issue, 100 µM
,
-meATP was applied to the P2Y2-R(
/
) tracheal and nasal cells. No
Ca2+i response was elicited by this compound in
either cell type (
Ca2+i in nose, 5.2 ± 3.9 nM, n = 3;
Ca2+i in
trachea, 4.8 ± 1.0 nM, n = 5).
Further, ATP-induced Ca2+i responses in
Ca2+-free buffer were not different from those found in the
presence of 1.3 mM Ca2+ in either wild type
(Fig. 6A) or
P2Y2-R(
/
) (Fig. 6B) epithelial cells. These
results strongly suggest that P2X receptors do not mediate the residual
ATP-induced responses.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of extracellular Ca2+ on
the ATP-induced Ca2+ response in tracheal and nasal
epithelial cells. Cells isolated from wild type (A) and
P2Y2-R( / ) (B) mice were challenged with 100 µM ATP in the presence and absence of extracellular
Ca2+ (n = 3-11).
|
|
Cross-desensitization experiments with P2Y2-R(
/
)
tracheal cells indicate that the Ca2+i response to
ATP was eliminated when the cells were pretreated with ADP or 2-MeSATP
but not with UTP (Fig. 7A).
Similarly, pretreatment with ATP or 2-MeSADP entirely abolished the
2-MeSATP-induced response in these cells (Fig. 7B). Studies
with P2Y2-R(
/
) nasal cells produced comparable results;
pretreatment with ADP, 2-MeSATP, or 2-MeSADP abolished the ATP-induced
Ca2+i signal (Fig. 7C). Similarly, the
Ca2+i response to 2-MeSATP was eliminated when
cells were pretreated with ATP, ADP, or 2-MeSADP (Fig. 7D).
These results suggest one common receptor for ATP, ADP, 2-MeSATP, and
2-MeSADP in the P2Y2-R(
/
) tracheal and nasal epithelial
cells. This pattern of agonists resembles the nucleotide-agonist
profile of P2Y1 receptor described in many species,
including the murine P2Y1 receptor (37).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 7.
Desensitization studies in
P2Y2-R( / ) tracheal and nasal epithelial cells.
A, tracheal cell Ca2+ responses induced by 100 µM ATP (A) or 2-MeSATP (B)
following no preaddition (None), or preaddition of 100 µM of nucleotide indicated at the bottom of
each column. Similar protocols were used with nasal
epithelial cells (C, D). The experiments were
carried out as described in the legend of Fig. 3. The values are
mean ± S.E. (n = 3-7). The asterisks
indicate significant differences between responses with or without
pretreatment (p < 0.05). n.d., not
determined.
|
|
To directly investigate the involvement of the P2Y1
receptor in P2Y2-R(
/
) airway epithelial
Ca2+i signaling, the effect of A3P5P, a
P2Y1 receptor-selective antagonist (38), on the
2-MeSADP-induced Ca2+i responses was studied (Fig.
8). 2-MeSADP (1 µM) induced substantial Ca2+i responses in both wild type (Fig.
8A) and P2Y2-R(
/
) tracheal cells (Fig.
8B). The mean values for 2-MeSADP-induced changes in
Ca2+i were 74.9 ± 23.2 nM
(n = 7) and 50.4 ± 17.4 nM
(n = 7) for wild type and P2Y2-R(
/
)
mice, respectively. A3P5P (100 µM) alone did not
stimulate Ca2+ responses, but it completely blocked the
effect of 2-MeSADP (Fig. 8, right traces). The
2-MeSADP-induced changes in Ca2+i in the presence
of A3P5P were significantly reduced compared with responses without
A3P5P: 9.8 ± 5.0 nM (n = 3) and 8.9 ± 3.7 nM (n = 4) in wild type and
P2Y2-R(
/
) cells, respectively. Similar inhibitory
effects of A3P5P were observed in P2Y2-R(
/
) nasal
epithelial cells; the mean changes in Ca2+i in
response to 1 µM 2-MeSADP were 91.2 ± 23.5 nM (n = 3) and 6.5 ± 2.5 nM (n = 3) in the absence and presence of
A3P5P, respectively. In contrast, A3P5P did not affect the
UTP-stimulated Ca2+i response in wild type cells
(Fig. 8A), consistent with the lack of effect of A3P5P on
the P2Y2 receptor. Moreover, the carbachol-induced response
in the P2Y2-R(
/
) cells also were not affected by A3P5P
(Fig. 8B), further excluding nonspecific effects of A3P5P on
Ca2+i signaling. Taken together, these data suggest
that the residual P2 receptor in the P2Y2-R(
/
) murine
airway epithelia is the P2Y1 receptor.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of A3P5P on the 2-MeSADP-induced
Ca2+ response in mouse tracheal epithelial cells. Wild
type (A) and P2Y2( / ) (B) mouse
tracheal cells were exposed to 1 µM 2-MeSADP in the
presence and absence of 100 µM A3P5P. Responsiveness of
the cells was tested by adding 100 µM UTP in wild type or
1 mM carbachol in P2Y2-R( / ) cells at the
completion of each experiment. The traces are representative of seven
independent experiments.
|
|
 |
DISCUSSION |
The murine P2Y2-R gene was
disrupted by homologous recombination in embryonic stem lines and mice
homozygous for the disrupted P2Y2-R
gene generated from these lines. These P2Y2-R-deficient mice provide a unique tool for characterization of extracellular nucleotide regulation of cell signaling.
We investigated three different cell types isolated from lungs of wild
type and P2Y2 receptor (-/-) mice: lung fibroblasts and
tracheal and nasal epithelial cells. Because of the absence of specific
and potent antagonists, binding assays have not been useful in studies
characterizing tissue-specific expression of nucleotide receptors (39).
Therefore, we have measured nucleotide-induced Ca2+
responses and, when possible, inositol lipid hydrolysis to characterize nucleotide receptor function in cells from these wild type and P2Y2 receptor-deficient mice.
A good correlation between Ca2+i responses and
inositol phosphate formation was observed in lung fibroblasts (Fig. 2,
A and B). The dose-effect relationships for
nucleotide agonists and Ca2+i and inositol
phosphate measurements were identical. The rank orders of agonist
potencies (UTP
ATP
ADP > UDP) were similar in both
assays and were consistent with the pharmacological profile of the
P2Y2 receptor. However, the recently cloned rat P2Y4 receptor displays a similar pattern of triphosphate
nucleotide responses (40, 41), raising the possibility that its mouse homologue may do so as well.
A definitive description of which nucleotide receptor subtype(s)
accounted for the effect of UTP and ATP in the murine lung fibroblast
resulted from the experiments with cells isolated from P2Y2-R(
/
) mice (Fig. 2, C and D).
These data, demonstrating that disruption of the gene encoding the
P2Y2 receptor completely abolished nucleotide-induced
inositol phosphate and Ca2+ responses, establish that the
P2Y2 is the only P2 receptor functionally expressed in
mouse lung fibroblasts. Further studies will be required to extend this
characterization to nonlung fibroblasts and the potential influence of
continuous culture to assess the relevance of this conclusion to those
in previous reports.
Because of smaller numbers and limited growth capacity of the
epithelial cells, we focused on nucleotide-induced
Ca2+i responses rather than on inositol lipid
hydrolysis in this cell type. Tracheal epithelial cells from wild type
mice exhibited a rank order of nucleotide-induced responses (Fig.
3A) similar to that reported with the cloned human and mouse
P2Y2 receptor (7, 10). Desensitization studies carried out
with wild type tracheal cells provided further support for the
hypothesis that a common UTP/ATP receptor is expressed in these cells
(Fig. 4).
Direct, unambiguous evidence for P2Y2 expression in the
murine trachea was provided by studies with P2Y2-R(
/
)
tracheal cells. The complete abolition of UTP-induced
Ca2+i responses clearly demonstrated that
P2Y2 receptor accounted for the effect of UTP in wild type
tracheal cells, and no other UTP-activated receptor (i.e.
P2Y4 receptor) was present (Fig. 5A). The
absence of effect of UDP in the P2Y2-R(
/
) cells also ruled out involvement of P2Y6 receptors. The major (75%)
reduction in ATP-stimulated Ca2+ response clearly
demonstrated that P2Y2 receptor was the predominant but not
unique receptor for ATP in this cell type. The reduction in the
magnitude of the response to 2-MeSATP suggests that this nonselective
P2Y1/P2X receptor agonist also stimulates the
P2Y2 receptor at high concentrations. This observation is
consistent with the effect of 2-MeSATP reported with the cloned
P2Y2 receptor (10).
Mouse nasal epithelial cells exhibited a profile of
nucleotide-stimulated responses similar to that observed in tracheal
cells (Figs. 3 and 4). The ATP/UTP responses were generally larger in wild type tracheal cells than in nasal cells, whereas the magnitude of
residual ATP-stimulated responses in P2Y2-R(
/
) cells
was similar in cells from each region (Fig. 5). This observation
suggests a higher level of expression of the P2Y2 receptor
in tracheal cells than nasal cells.
A second objective of our study was to identify additional nucleotide
receptor(s) that might be expressed in mouse airway epithelial cells.
The absence of specific agonists and antagonists for most of the P2
receptors makes it difficult to classify multiple receptors in a
complex system. However, the P2Y2-R(
/
) mouse model
facilitated these studies.
Our results provide direct evidence for the functional expression of P2
receptor(s) other than P2Y2 that are activated by adenine
nucleotide agonists in murine tracheal and nasal epithelial cells. The
involvement of P1 adenosine receptors in the ATP-induced Ca2+ response was ruled out on the bases that adenosine did
not stimulate elevation in intracellular Ca2+ levels and
that adenosine deaminase pretreatment did not affect the response to
ATP in P2Y2-R(
/
) cells.
,
-meATP, originally thought to be specific for all P2X receptors (4), is now known to be
active only at P2X1 and P2X3 receptors (36, 42,
43). In mouse airway epithelial cells,
,
-meATP was inactive in
terms of Ca2+ signaling (see "Results") as well as
Cl
secretion (33). We cannot entirely rule out the
involvement of P2X receptors solely on the basis of the absence of
,
-meATP-induced responses. However, the experiments carried out
in Ca2+-free buffer (Fig. 6) clearly demonstrated that
ATP-stimulated Ca2+ responses primarily reflected release
from internal stores and not direct opening of plasma membrane P2X
(Ca2+) channels. These findings strongly suggest that the
P2X receptors are not functionally expressed in these cells.
The residual effects of ATP, ADP, 2-MeSATP, and 2-MeSADP found in
P2Y2-R(
/
) cells (Fig. 5), coupled with the
desensitization studies (Fig. 7), are more consistent with the
expression of P2Y1 receptor (44-46) than a
P2Y11 receptor, because the latter is not activated by the
diphosphate analogues (13). The substantial Ca2+i
responses elicited by ADP and 2-MeSADP in the P2Y2-R(
/
) cells (Fig. 5), coupled with the antagonistic effect of A3P5P on the
Ca2+i response to 2-MeSADP-induced responses (Fig.
8), strongly supports the hypothesis that the residual nucleotide
receptor in the P2Y2-R(
/
) airway cells is in fact the
P2Y1 receptor.
The results of Ca2+i measurements with tracheal
epithelial cells can be compared with the data obtained from the
tracheal Cl
secretory studies in the accompanying paper
(33). Our studies were carried out on isolated tracheal cells grown on
glass coverslips, providing access of added agonists to apical and
basolateral membrane surfaces. In contrast, the Cl
measurements were performed with freshly excised tracheas with additions only to the apical surface. Despite these differences, the
pharmacological profiles determined by theses two methods were
generally similar in tracheal specimens and revealed that the
P2Y2 receptor was the dominant receptor mediating both
Ca2+i and Cl
secretory responses in
wild type mice. A slight difference was that in
P2Y2-R(
/
) tracheal epithelia UDP had a minor but potent effect on Cl
secretion (33), whereas negligible UDP
responses were observed in the Ca2+i studies (Fig.
5). The simplest explanation for this discrepancy is that the
UDP-activated receptor, probably P2Y6, was down-regulated
during culture on glass coverslips.
In summary, murine lung fibroblasts as well as tracheal and nasal
epithelial cells from wild type mice exhibit P2Y2-like
pharmacologic responses to extracellular nucleotide additions.
Comparative studies of cells from P2Y2-R(+/+) and
P2Y2-R(
/
) mice provided direct evidence for
P2Y2 receptor function in all three cell types. The P2Y2 receptor appears likely to be the only P2 receptor in
mouse lung fibroblasts and is the predominant P2 receptor in airway epithelial cells. In addition, the P2Y2-R(
/
) mouse
model made it possible to functionally characterize and identify
another P2 receptor in airway epithelia, which was masked by the
activity of the dominant P2Y2 receptor. The residual
nucleotide receptor in mouse tracheal and nasal epithelial cells is
most likely the P2Y1 receptor. Although conclusions
regarding humans cannot be directly drawn from studies performed in
mice, the P2Y2-R(
/
) mouse model system provides a
unique tool for tissue-specific nucleotide receptor function.
 |
ACKNOWLEDGEMENTS |
We are grateful to Drs. Barbara R. Grubb,
James R. Yankaskas, and Anthony M. Paradiso for helpful advice and
contribution to the isolation and culturing of murine pulmonary cells.
We also thank Diana L. Walstad for technical assistance.
 |
FOOTNOTES |
*
Supported by National Institutes of Health (NIH) Grants
HL58554 and DK51791 (to B. H. K.), NIH Grant HL34322, and Cystic
Fibrosis Foundation Grants R026 and HOMOLY98I0.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Cystic
Fibrosis/Pulmonary Research and Treatment Center, CB 7248, 7011 Thurston-Bowles Building, The University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599-7248. Tel.: 919-966-1077; Fax:
919-966-7524; E-mail: rboucher@med.unc.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
P2Y2-R, P2Y2 receptor;
2-MeSATP, 2-methylthioadenosine
5'-triphosphate;
2-MeSADP, 2-methylthioadenosine 5'-diphosphate;
,
-meATP,
,
-methylene adenosine 5'-triphosphate;
A3P5P, adenosine 3',5'-diphosphate;
EC50, 50% of maximal
effective concentration;
SSC, sodium chloride-sodium citrate.
 |
REFERENCES |
| 1.
|
Gordon, J. L.
(1986)
Biochem. J.
233,
309-319[Medline]
[Order article via Infotrieve]
|
| 2.
|
Dubyak, G. R.,
and El-Moatassim, C.
(1993)
Am. J. Physiol.
265,
C577-C606[Abstract/Free Full Text]
|
| 3.
|
Mason, S. J.,
Paradiso, A. M.,
and Boucher, R. C.
(1991)
Br. J. Pharmacol.
103,
1649-1656[Medline]
[Order article via Infotrieve]
|
| 4.
|
Burnstock, G.,
and Kennedy, C.
(1985)
Gen. Pharmacol.
16,
433-440[Medline]
[Order article via Infotrieve]
|
| 5.
|
Zeiske, W.
(1978)
Biochim. Biophys. Acta
509,
218-229[Medline]
[Order article via Infotrieve]
|
| 6.
|
Seifert, R.,
and Schultz, G.
(1989)
Trends Pharmacol. Sci.
10,
365-369[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lustig, K. D.,
Shiau, A. K.,
Brake, A. J.,
and Julius, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5113-5117[Abstract/Free Full Text]
|
| 8.
|
Parr, C. E.,
Sullivan, D. M.,
Paradiso, A. M.,
Lazarowski, E. R.,
Burch, L. H.,
Olsen, J. C.,
Erb, L.,
Weisman, G. A.,
Boucher, R. C.,
and Turner, J. T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3275-3279[Abstract/Free Full Text]
|
| 9.
|
Nicholas, R. A.,
Watt, W. C.,
Lazarowski, E. R.,
Li, Q.,
and Harden, T. K.
(1996)
Mol. Pharmacol.
50,
224-229[Abstract]
|
| 10.
|
Lazarowski, E. R.,
Watt, W. C.,
Stutts, M. J.,
Boucher, R. C.,
and Harden, T. K.
(1995)
Br. J. Pharmacol.
116,
1619-1627[Medline]
[Order article via Infotrieve]
|
| 11.
|
Harden, T. K.,
Boyer, J. L.,
and Nicholas, R. A.
(1995)
Annu. Rev. Pharmacol. Toxicol.
35,
541-579[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Fredholm, B. B.,
Abbracchio, M. P.,
Burnstock, G.,
Dubyak, G. R.,
Harden, T. K.,
Jacobson, K. A.,
Schwabe, U.,
and Williams, M.
(1997)
Trends Pharmacol. Sci.
18,
79-82[Medline]
[Order article via Infotrieve]
|
| 13.
|
Communi, D.,
Govaerts, C.,
Parmentier, M.,
and Boeynaems, J. M.
(1997)
J. Biol. Chem.
272,
31969-31973[Abstract/Free Full Text]
|
| 14.
|
Okada, Y.,
Yada, T.,
Ohno-Shosaku, T.,
Oiki, S.,
Ueda, S.,
and Machida, K.
(1984)
Exp. Cell Res.
152,
552-557[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Rathbone, M. P.,
Middlemiss, P. J.,
Gysbers, J. W.,
DeForge, S.,
Costello, P.,
and Del Maestro, R. F.
(1992)
In Vitro Cell. Dev. Biol.
28A,
529-536
|
| 16.
|
Joseph, J.,
Grierson, I.,
and Hitchings, R. A.
(1988)
Exp. Cell Res.
176,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Gonzalez, F. A.,
Bonapace, E.,
Belzer, I.,
Friedberg, I.,
and Heppel, L. A.
(1989)
Biochem. Biophys. Res. Commun.
164,
706-713[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Pizzo, P.,
Murgia, M.,
Zambon, A.,
Zanovello, P.,
Bronte, V.,
Pietrobon, D.,
and Di Virgilio, F.
(1992)
J. Immunol.
149,
3372-3378[Abstract]
|
| 19.
|
Erb, L.,
Lustig, K. D.,
Ahmed, A. H.,
Gonzalez, F. A.,
and Weisman, G. A.
(1990)
J. Biol. Chem.
265,
7424-7431[Abstract/Free Full Text]
|
| 20.
|
Gubits, R. M.,
Wollack, J. B., Yu, H.,
and Liu, W. K.
(1990)
Mol. Brain Res.
8,
275-281[Medline]
[Order article via Infotrieve]
|
| 21.
|
Rozengurt, E.
(1982)
Exp. Cell Res.
139,
71-78[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Tepel, M.,
Loewe, S.,
Nofer, J. R.,
Assmann, G.,
Schlueter, H.,
and Zidek, W.
(1996)
Biochim. Biophys. Acta
1312,
145-150[Medline]
[Order article via Infotrieve]
|
| 23.
|
Giovannardi, S.,
Racca, C.,
Bertollini, L.,
Sturani, E.,
and Peres, A.
(1992)
Exp. Cell Res.
202,
398-404[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Fine, J.,
Cole, P.,
and Davidson, J. S.
(1989)
Biochem. J.
263,
371-376[Medline]
[Order article via Infotrieve]
|
| 25.
|
Jiang, C.,
Finkbeiner, W. E.,
Widdicombe, J. H.,
McCray, P. B., Jr.,
and Miller, S. S.
(1993)
Science
262,
424-427[Abstract/Free Full Text]
|
| 26.
|
Lethem, M. I.,
Dowell, M. L.,
Van Scott, M.,
Yankaskas, J. R.,
Egan, T.,
Boucher, R. C.,
and Davis, C. W.
(1993)
Am. J. Respir. Cell Mol. Biol.
9,
315-322
|
| 27.
|
Davis, C. W.,
Dowell, M. L.,
Lethem, M. I.,
and Van Scott, M.
(1992)
Am. J. Physiol.
262,
C1313-C1323[Abstract/Free Full Text]
|
| 28.
|
Geary, C. A.,
Davis, C. W.,
Paradiso, A. M.,
and Boucher, R. C.
(1995)
Am. J. Physiol.
268,
L1021-L1028[Abstract/Free Full Text]
|
| 29.
|
Brown, H. A.,
Lazarowski, E. R.,
Boucher, R. C.,
and Harden, T. K.
(1991)
Mol. Pharmacol.
40,
648-655[Abstract]
|
| 30.
|
Benali, R.,
Pierrot, D.,
Zahm, J. M.,
de Bentzmann, S.,
and Puchelle, E.
(1994)
Am. J. Respir. Cell Mol. Biol.
10,
363-368[Abstract]
|
| 31.
|
Lazarowski, E. R.,
Paradiso, A. M.,
Watt, W. C.,
Harden, T. K.,
and Boucher, R. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2599-2603[Abstract/Free Full Text]
|
| 32.
|
Lazarowski, E. R.,
Mason, S. J.,
Clarke, L. L.,
Harden, T. K.,
and Boucher, R. C.
(1992)
Br. J. Pharmacol.
106,
774-782[Medline]
[Order article via Infotrieve]
|
| 33.
| Cressman, V. L., Lazarowski, E., Homolya, L., Boucher, R. C.,
Koller, B. H., and Grubb, B. R. (1999) 274, 26461-26468
|
| 34.
|
Paradiso, A. M.,
Mason, S. J.,
Lazarowski, E. R.,
and Boucher, R. C.
(1995)
Nature
377,
643-646[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Grynkiewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450[Abstract/Free Full Text]
|
| 36.
|
Evans, R. J.,
Surprenant, A.,
and North, R. A.
(1998)
in
The P2 Nucleotide Receptors
(Turner, J. T.
, Weisman, G. A.
, and Fedan, J. S., eds)
, pp. 43-61, Humana Press, Totowa, NJ
|
| 37.
|
Tokuyama, Y.,
Hara, M.,
Jones, E. M. C.,
Fan, Z.,
and Bell, G. I.
(1995)
Biochem. Biophys. Res. Commun.
211,
211-218[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Boyer, J. L.,
Romero-Avila, T.,
Schachter, J. B.,
and Harden, T. K.
(1996)
Mol. Pharmacol.
50,
1323-1329[Abstract]
|
| 39.
|
Schachter, J. B.,
and Harden, T. K.
(1997)
Br. J. Pharmacol.
121,
338-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Webb, T. E.,
Henderson, D. J.,
Roberts, J. A.,
and Barnard, E. A.
(1998)
J. Neurochem.
71,
1348-1357[Medline]
[Order article via Infotrieve]
|
| 41.
|
Bogdanov, Y. D.,
Wildman, S. S.,
Clements, M. P.,
King, B. F.,
and Burnstock, G.
(1998)
Br. J. Pharmacol.
124,
428-430[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Valera, S.,
Hussy, N.,
Evans, R. J.,
Adami, N.,
North, R. A.,
Surprenant, A.,
and Buell, G.
(1994)
Nature
371,
516-519[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Chen, C. C.,
Akopian, A. N.,
Sivilotti, L.,
Colquhoun, D.,
Burnstock, G.,
and Wood, J. N.
(1995)
Nature
377,
428-431[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Webb, T. E.,
Simon, J.,
Krishek, B. J.,
Bateson, A. N.,
Smart, T. G.,
King, B. F.,
Burnstock, G.,
and Barnard, E. A.
(1993)
FEBS Lett.
324,
219-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Filtz, T. M.,
Li, Q.,
Boyer, J. L.,
Nicholas, R. A.,
and Harden, T. K.
(1994)
Mol. Pharmacol.
46,
8-14[Abstract]
|
| 46.
|
Schachter, J. B.,
Li, Q.,
Boyer, J. L.,
Nicholas, R. A.,
and Harden, T. K.
(1996)
Br. J. Pharmacol.
118,
167-173[Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. M. Lorenzo, W. Liedtke, M. J. Sanderson, and M. A. Valverde
TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells
PNAS,
August 26, 2008;
105(34):
12611 - 12616.
[Abstract]
[Full Text]
[PDF]
|
 |
|